Docking studies on NSAID/COX-2 isozyme complexes using contact statistics analysis

The selective inhibition of COX-2 isozymes should lead to a new generation of NSAIDs with significantly reduced side effects; e.g. celecoxib (Celebrex) and rofecoxib (Vioxx). To obtain inhibitors with higher selectivity it has become essential to gain additional insight into the details of the inter...

Full description

Saved in:
Bibliographic Details
Published inJournal of computer-aided molecular design Vol. 18; no. 11; pp. 683 - 696
Main Authors Ermondi, Giuseppe, Caron, Giulia, Lawrence, Raelene, Longo, Dario
Format Journal Article
LanguageEnglish
Published Netherlands Springer Nature B.V 01.11.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The selective inhibition of COX-2 isozymes should lead to a new generation of NSAIDs with significantly reduced side effects; e.g. celecoxib (Celebrex) and rofecoxib (Vioxx). To obtain inhibitors with higher selectivity it has become essential to gain additional insight into the details of the interactions between COX isozymes-and NSAIDs. Although X-ray structures of COX-2 complexed with a small number of ligands are available, experimental data are missing for two well-known selective COX-2 inhibitors (rofecoxib and nimesulide) and docking results reported are controversial. We use a combination of a traditional docking procedure with a new computational tool (Contact Statistics analysis) that identifies the best orientation among a number of solutions to shed some light on this topic.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0920-654X
1573-4951
DOI:10.1007/s10822-004-6258-1